Peter Nagele
Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nitrous Oxide | 17 | 2021 | 102 | 6.590 |
Why?
| Troponin T | 12 | 2020 | 31 | 5.090 |
Why?
| Myocardial Infarction | 13 | 2021 | 368 | 4.860 |
Why?
| Anesthetics, Inhalation | 13 | 2020 | 91 | 3.880 |
Why?
| Troponin I | 6 | 2019 | 26 | 2.910 |
Why?
| Vitamin B Complex | 5 | 2014 | 22 | 2.510 |
Why?
| Surgical Procedures, Operative | 8 | 2017 | 186 | 2.270 |
Why?
| Electroconvulsive Therapy | 3 | 2019 | 30 | 2.200 |
Why?
| Depressive Disorder, Major | 4 | 2022 | 136 | 2.200 |
Why?
| Postoperative Complications | 15 | 2021 | 2189 | 1.950 |
Why?
| Homocysteine | 6 | 2013 | 29 | 1.920 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2014 | 26 | 1.890 |
Why?
| Anesthesia, Inhalation | 5 | 2014 | 37 | 1.830 |
Why?
| Emergency Medical Services | 7 | 2016 | 177 | 1.620 |
Why?
| Cardiopulmonary Resuscitation | 5 | 2016 | 159 | 1.590 |
Why?
| Natriuretic Peptide, Brain | 2 | 2021 | 69 | 1.520 |
Why?
| Troponin | 2 | 2019 | 12 | 1.470 |
Why?
| Electrocardiography | 8 | 2019 | 571 | 1.430 |
Why?
| Out-of-Hospital Cardiac Arrest | 3 | 2016 | 45 | 1.400 |
Why?
| Peptide Fragments | 2 | 2021 | 468 | 1.320 |
Why?
| Myocardium | 2 | 2020 | 535 | 1.320 |
Why?
| Perioperative Care | 4 | 2020 | 158 | 1.260 |
Why?
| Receptors, N-Methyl-D-Aspartate | 4 | 2020 | 115 | 1.230 |
Why?
| Long QT Syndrome | 3 | 2016 | 36 | 1.210 |
Why?
| Humans | 70 | 2022 | 80837 | 1.120 |
Why?
| Adrenergic beta-Antagonists | 3 | 2020 | 163 | 1.090 |
Why?
| Female | 48 | 2022 | 43279 | 1.050 |
Why?
| Male | 47 | 2022 | 40407 | 1.040 |
Why?
| Preoperative Care | 3 | 2021 | 400 | 1.040 |
Why?
| Vitamins | 2 | 2014 | 73 | 1.010 |
Why?
| Exercise Test | 2 | 2021 | 167 | 0.990 |
Why?
| Postoperative Period | 7 | 2021 | 300 | 0.980 |
Why?
| Prospective Studies | 15 | 2022 | 3961 | 0.970 |
Why?
| Cytochrome P-450 CYP2D6 | 2 | 2013 | 50 | 0.950 |
Why?
| Middle Aged | 32 | 2021 | 24750 | 0.880 |
Why?
| Antidepressive Agents | 4 | 2021 | 105 | 0.850 |
Why?
| Heart Injuries | 1 | 2020 | 15 | 0.850 |
Why?
| Myocardial Ischemia | 2 | 2019 | 170 | 0.800 |
Why?
| Aged | 23 | 2022 | 17903 | 0.790 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2021 | 105 | 0.750 |
Why?
| Echocardiography, Stress | 1 | 2018 | 20 | 0.750 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 2021 | 125 | 0.750 |
Why?
| Terminology as Topic | 1 | 2020 | 210 | 0.740 |
Why?
| Cohort Studies | 12 | 2021 | 2627 | 0.730 |
Why?
| Tinnitus | 1 | 2018 | 19 | 0.730 |
Why?
| Perioperative Period | 3 | 2013 | 26 | 0.710 |
Why?
| Heart Diseases | 2 | 2019 | 309 | 0.710 |
Why?
| Treatment Outcome | 12 | 2021 | 7653 | 0.710 |
Why?
| Air Ambulances | 3 | 2014 | 11 | 0.710 |
Why?
| Acute Coronary Syndrome | 1 | 2018 | 41 | 0.710 |
Why?
| Coronary Artery Disease | 2 | 2022 | 355 | 0.700 |
Why?
| Coronary Angiography | 4 | 2022 | 222 | 0.680 |
Why?
| Orthopedic Procedures | 3 | 2020 | 131 | 0.660 |
Why?
| Adolescent | 14 | 2021 | 8878 | 0.660 |
Why?
| Torsades de Pointes | 2 | 2013 | 8 | 0.650 |
Why?
| Adult | 21 | 2021 | 25137 | 0.640 |
Why?
| Predictive Value of Tests | 8 | 2022 | 1705 | 0.620 |
Why?
| Double-Blind Method | 7 | 2021 | 1829 | 0.620 |
Why?
| Life Support Care | 2 | 2007 | 46 | 0.610 |
Why?
| Blood Cells | 1 | 2015 | 35 | 0.600 |
Why?
| Anesthesia, General | 2 | 2016 | 128 | 0.590 |
Why?
| Depressive Disorder, Treatment-Resistant | 1 | 2014 | 2 | 0.580 |
Why?
| Intraoperative Complications | 2 | 2013 | 180 | 0.580 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2020 | 828 | 0.580 |
Why?
| Risk Factors | 10 | 2020 | 5257 | 0.570 |
Why?
| Austria | 7 | 2020 | 19 | 0.570 |
Why?
| Cardiovascular Diseases | 2 | 2020 | 780 | 0.570 |
Why?
| Folic Acid | 2 | 2011 | 48 | 0.550 |
Why?
| Spine | 1 | 2015 | 119 | 0.550 |
Why?
| Malignant Hyperthermia | 1 | 2013 | 2 | 0.540 |
Why?
| Survival Analysis | 2 | 2016 | 1535 | 0.540 |
Why?
| Vitamin B 12 | 2 | 2011 | 19 | 0.530 |
Why?
| Ryanodine Receptor Calcium Release Channel | 1 | 2013 | 25 | 0.520 |
Why?
| Nerve Block | 1 | 2014 | 55 | 0.520 |
Why?
| Metoprolol | 1 | 2013 | 31 | 0.510 |
Why?
| Ferredoxin-NADP Reductase | 2 | 2011 | 15 | 0.510 |
Why?
| Exome | 1 | 2013 | 113 | 0.510 |
Why?
| Caenorhabditis elegans | 2 | 2005 | 204 | 0.490 |
Why?
| Anesthetics, General | 1 | 2012 | 9 | 0.490 |
Why?
| Skiing | 1 | 2012 | 4 | 0.490 |
Why?
| Contusions | 1 | 2012 | 9 | 0.490 |
Why?
| Pain Measurement | 1 | 2014 | 301 | 0.480 |
Why?
| Analgesics, Opioid | 2 | 2014 | 373 | 0.480 |
Why?
| Calcium Channels | 1 | 2013 | 194 | 0.470 |
Why?
| Heart Rate | 3 | 2012 | 536 | 0.470 |
Why?
| Depression | 3 | 2022 | 405 | 0.460 |
Why?
| Food, Fortified | 1 | 2011 | 7 | 0.460 |
Why?
| Polymorphism, Genetic | 3 | 2013 | 780 | 0.450 |
Why?
| Fractures, Bone | 1 | 2012 | 114 | 0.450 |
Why?
| Pain, Postoperative | 1 | 2014 | 235 | 0.440 |
Why?
| Shock, Hemorrhagic | 1 | 2010 | 16 | 0.430 |
Why?
| Risk Assessment | 7 | 2021 | 2205 | 0.430 |
Why?
| Rescue Work | 2 | 2012 | 7 | 0.420 |
Why?
| Brain Injuries | 1 | 2012 | 136 | 0.420 |
Why?
| Retrospective Studies | 11 | 2021 | 7532 | 0.420 |
Why?
| Hyperhomocysteinemia | 1 | 2010 | 11 | 0.420 |
Why?
| Oxygen Inhalation Therapy | 1 | 2010 | 54 | 0.420 |
Why?
| Aged, 80 and over | 7 | 2021 | 6383 | 0.400 |
Why?
| Wounds and Injuries | 3 | 2011 | 221 | 0.380 |
Why?
| Consensus | 2 | 2021 | 282 | 0.380 |
Why?
| Anesthesiology | 2 | 2019 | 157 | 0.380 |
Why?
| Physicians | 1 | 2016 | 591 | 0.370 |
Why?
| Xenon | 2 | 2005 | 6 | 0.370 |
Why?
| Receptors, Glutamate | 2 | 2005 | 32 | 0.370 |
Why?
| Aminophylline | 1 | 2008 | 12 | 0.360 |
Why?
| Young Adult | 6 | 2021 | 5780 | 0.360 |
Why?
| Anesthesia, Intravenous | 1 | 2008 | 37 | 0.350 |
Why?
| Cross-Over Studies | 3 | 2020 | 394 | 0.350 |
Why?
| Pilot Projects | 2 | 2022 | 798 | 0.340 |
Why?
| Anesthesia | 1 | 2009 | 172 | 0.340 |
Why?
| Genetic Variation | 2 | 2011 | 1333 | 0.340 |
Why?
| Data Interpretation, Statistical | 2 | 2013 | 299 | 0.330 |
Why?
| Child | 8 | 2020 | 6587 | 0.320 |
Why?
| Administration, Inhalation | 2 | 2018 | 169 | 0.320 |
Why?
| Time Factors | 5 | 2017 | 5282 | 0.320 |
Why?
| Synaptic Transmission | 2 | 2005 | 268 | 0.320 |
Why?
| Genome, Human | 1 | 2011 | 738 | 0.320 |
Why?
| Child, Preschool | 6 | 2015 | 3642 | 0.320 |
Why?
| Emergency Medicine | 1 | 2007 | 121 | 0.310 |
Why?
| Vesicle-Associated Membrane Protein 2 | 1 | 2005 | 2 | 0.310 |
Why?
| Syntaxin 1 | 1 | 2005 | 7 | 0.310 |
Why?
| Genomics | 1 | 2011 | 631 | 0.310 |
Why?
| Synaptosomal-Associated Protein 25 | 1 | 2005 | 14 | 0.310 |
Why?
| SNARE Proteins | 1 | 2005 | 24 | 0.310 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2005 | 87 | 0.300 |
Why?
| Oxygen | 1 | 2010 | 701 | 0.290 |
Why?
| Prognosis | 6 | 2020 | 3603 | 0.290 |
Why?
| Glutamic Acid | 1 | 2005 | 172 | 0.280 |
Why?
| Genetic Predisposition to Disease | 1 | 2013 | 2168 | 0.280 |
Why?
| Kaplan-Meier Estimate | 3 | 2017 | 868 | 0.270 |
Why?
| Mutation | 2 | 2013 | 3737 | 0.270 |
Why?
| Electroencephalography | 1 | 2008 | 687 | 0.260 |
Why?
| Single-Blind Method | 2 | 2017 | 157 | 0.260 |
Why?
| Age Factors | 3 | 2015 | 1842 | 0.260 |
Why?
| Disease Models, Animal | 1 | 2010 | 2195 | 0.260 |
Why?
| Head and Neck Neoplasms | 1 | 2010 | 972 | 0.260 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2004 | 100 | 0.250 |
Why?
| Burns | 2 | 2014 | 106 | 0.240 |
Why?
| Preoperative Period | 2 | 2013 | 82 | 0.240 |
Why?
| Plaque, Atherosclerotic | 1 | 2022 | 36 | 0.230 |
Why?
| Reproducibility of Results | 2 | 2019 | 2551 | 0.230 |
Why?
| Research | 1 | 2003 | 254 | 0.230 |
Why?
| Monitoring, Intraoperative | 2 | 2016 | 141 | 0.220 |
Why?
| Unnecessary Procedures | 1 | 2021 | 47 | 0.220 |
Why?
| Anxiety Disorders | 1 | 2022 | 110 | 0.220 |
Why?
| Coronary Circulation | 1 | 2022 | 131 | 0.220 |
Why?
| Abdomen | 1 | 2021 | 112 | 0.220 |
Why?
| Up-Regulation | 2 | 2017 | 680 | 0.220 |
Why?
| Myocardial Perfusion Imaging | 1 | 2022 | 61 | 0.220 |
Why?
| Infant | 4 | 2012 | 3007 | 0.220 |
Why?
| Periodicals as Topic | 1 | 2003 | 160 | 0.220 |
Why?
| Neuromuscular Nondepolarizing Agents | 1 | 2000 | 18 | 0.210 |
Why?
| Huntington Disease | 1 | 2000 | 36 | 0.210 |
Why?
| Heart Arrest | 2 | 2021 | 256 | 0.210 |
Why?
| Infarction | 1 | 2020 | 24 | 0.210 |
Why?
| Methyl Ethers | 1 | 2000 | 33 | 0.210 |
Why?
| Appendectomy | 1 | 2000 | 30 | 0.210 |
Why?
| Veterans | 1 | 2020 | 51 | 0.210 |
Why?
| Isoquinolines | 1 | 2000 | 72 | 0.210 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 2279 | 0.210 |
Why?
| Ketamine | 1 | 2020 | 23 | 0.210 |
Why?
| Coronary Vessels | 1 | 2022 | 189 | 0.210 |
Why?
| Anxiety | 1 | 2022 | 248 | 0.200 |
Why?
| Emergencies | 1 | 2000 | 110 | 0.200 |
Why?
| Digestive System Surgical Procedures | 1 | 2021 | 128 | 0.200 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2020 | 67 | 0.200 |
Why?
| Nutrition Surveys | 1 | 2019 | 84 | 0.190 |
Why?
| Hip Joint | 1 | 2019 | 66 | 0.190 |
Why?
| Walking | 1 | 2019 | 75 | 0.190 |
Why?
| Intention to Treat Analysis | 1 | 2018 | 66 | 0.190 |
Why?
| Vascular Surgical Procedures | 1 | 2019 | 154 | 0.180 |
Why?
| Enzyme Stability | 1 | 2017 | 40 | 0.180 |
Why?
| Missouri | 1 | 2017 | 27 | 0.180 |
Why?
| Hypotension | 1 | 2017 | 73 | 0.170 |
Why?
| Research Design | 1 | 2020 | 545 | 0.170 |
Why?
| Follow-Up Studies | 2 | 2018 | 3717 | 0.160 |
Why?
| Exercise | 1 | 2019 | 273 | 0.160 |
Why?
| Anesthetics | 2 | 2009 | 60 | 0.160 |
Why?
| Anesthesia, Spinal | 1 | 2016 | 15 | 0.160 |
Why?
| Patient Selection | 1 | 2020 | 656 | 0.160 |
Why?
| Echocardiography | 1 | 2021 | 864 | 0.160 |
Why?
| Electrocardiography, Ambulatory | 1 | 2016 | 28 | 0.160 |
Why?
| Genotype | 2 | 2013 | 1802 | 0.150 |
Why?
| Reference Values | 1 | 2017 | 675 | 0.150 |
Why?
| Pancytopenia | 1 | 2015 | 21 | 0.150 |
Why?
| Leukopenia | 1 | 2015 | 61 | 0.150 |
Why?
| Pregnancy | 1 | 2022 | 2717 | 0.140 |
Why?
| Death, Sudden, Cardiac | 1 | 2015 | 51 | 0.140 |
Why?
| Sample Size | 2 | 2013 | 118 | 0.140 |
Why?
| Trauma Severity Indices | 1 | 2014 | 44 | 0.140 |
Why?
| ROC Curve | 1 | 2017 | 740 | 0.140 |
Why?
| Thrombocytopenia | 1 | 2015 | 163 | 0.140 |
Why?
| Anemia | 1 | 2015 | 127 | 0.140 |
Why?
| Incidence | 2 | 2016 | 1593 | 0.130 |
Why?
| Body Surface Area | 1 | 2013 | 33 | 0.130 |
Why?
| Patient Discharge | 1 | 2016 | 220 | 0.130 |
Why?
| Calcium Channels, L-Type | 1 | 2013 | 44 | 0.130 |
Why?
| Endpoint Determination | 1 | 2013 | 59 | 0.130 |
Why?
| Fluid Therapy | 1 | 2013 | 48 | 0.130 |
Why?
| Stereoisomerism | 1 | 2013 | 97 | 0.130 |
Why?
| Drug Administration Schedule | 1 | 2015 | 926 | 0.130 |
Why?
| Psychiatric Status Rating Scales | 1 | 2014 | 468 | 0.120 |
Why?
| Snow Sports | 1 | 2012 | 1 | 0.120 |
Why?
| Mountaineering | 1 | 2012 | 2 | 0.120 |
Why?
| Preanesthetic Medication | 2 | 2010 | 6 | 0.120 |
Why?
| Bicycling | 1 | 2012 | 9 | 0.120 |
Why?
| Spinal Injuries | 1 | 2012 | 22 | 0.120 |
Why?
| Facial Injuries | 1 | 2012 | 18 | 0.120 |
Why?
| Gene Dosage | 1 | 2013 | 208 | 0.120 |
Why?
| Algorithms | 2 | 2013 | 1766 | 0.120 |
Why?
| Vasoconstrictor Agents | 1 | 2012 | 52 | 0.120 |
Why?
| Human Genome Project | 1 | 2011 | 18 | 0.120 |
Why?
| Lower Extremity | 1 | 2012 | 59 | 0.120 |
Why?
| United States | 4 | 2021 | 6156 | 0.120 |
Why?
| Upper Extremity | 1 | 2012 | 53 | 0.120 |
Why?
| Severity of Illness Index | 2 | 2010 | 1712 | 0.120 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 2003 | 0.120 |
Why?
| Folic Acid Antagonists | 1 | 2011 | 20 | 0.110 |
Why?
| Utilization Review | 1 | 2011 | 22 | 0.110 |
Why?
| Risk | 1 | 2013 | 676 | 0.110 |
Why?
| Multivariate Analysis | 2 | 2012 | 968 | 0.110 |
Why?
| Neurologic Examination | 1 | 2011 | 116 | 0.110 |
Why?
| Rural Population | 1 | 2011 | 122 | 0.110 |
Why?
| Causality | 1 | 2010 | 80 | 0.110 |
Why?
| Neck Dissection | 1 | 2010 | 70 | 0.110 |
Why?
| Confidence Intervals | 1 | 2010 | 227 | 0.100 |
Why?
| Health Surveys | 1 | 2011 | 243 | 0.100 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 234 | 0.100 |
Why?
| Survival Rate | 2 | 2014 | 1852 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2010 | 312 | 0.100 |
Why?
| Environment | 1 | 2011 | 209 | 0.100 |
Why?
| Urban Population | 1 | 2011 | 219 | 0.100 |
Why?
| Length of Stay | 2 | 2021 | 680 | 0.100 |
Why?
| Sex Characteristics | 1 | 2011 | 295 | 0.100 |
Why?
| Swine | 1 | 2010 | 547 | 0.100 |
Why?
| Critical Illness | 1 | 2011 | 276 | 0.090 |
Why?
| Anesthetics, Intravenous | 1 | 2008 | 49 | 0.090 |
Why?
| Germany | 1 | 2007 | 69 | 0.090 |
Why?
| Bronchodilator Agents | 1 | 2008 | 60 | 0.090 |
Why?
| Clinical Competence | 1 | 2013 | 684 | 0.090 |
Why?
| Sex Factors | 1 | 2011 | 1046 | 0.090 |
Why?
| Academic Medical Centers | 1 | 2010 | 379 | 0.090 |
Why?
| Shock | 1 | 2007 | 45 | 0.090 |
Why?
| Practice Guidelines as Topic | 2 | 2015 | 1043 | 0.080 |
Why?
| Calcium | 1 | 2012 | 1164 | 0.080 |
Why?
| Base Sequence | 1 | 2011 | 2367 | 0.080 |
Why?
| Genetic Linkage | 1 | 2009 | 623 | 0.080 |
Why?
| Smoking | 1 | 2011 | 544 | 0.080 |
Why?
| Trauma Centers | 1 | 2007 | 109 | 0.080 |
Why?
| Gene Frequency | 1 | 2009 | 648 | 0.080 |
Why?
| Europe | 1 | 2007 | 301 | 0.080 |
Why?
| Animals | 4 | 2010 | 26046 | 0.080 |
Why?
| Logistic Models | 1 | 2010 | 1108 | 0.080 |
Why?
| Comorbidity | 1 | 2010 | 894 | 0.080 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 796 | 0.080 |
Why?
| Phenotype | 1 | 2013 | 2226 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2011 | 1391 | 0.080 |
Why?
| Emergency Medical Technicians | 1 | 2005 | 12 | 0.080 |
Why?
| Manikins | 1 | 2005 | 39 | 0.070 |
Why?
| Respiratory Mechanics | 1 | 2005 | 104 | 0.070 |
Why?
| Urban Health Services | 1 | 2004 | 40 | 0.070 |
Why?
| Blood Pressure | 2 | 2008 | 1150 | 0.070 |
Why?
| Acetylcholine | 1 | 2004 | 171 | 0.070 |
Why?
| Receptors, AMPA | 1 | 2004 | 77 | 0.070 |
Why?
| Age Distribution | 2 | 2014 | 206 | 0.070 |
Why?
| Recombinant Proteins | 1 | 2005 | 1021 | 0.060 |
Why?
| Isoflurane | 1 | 2003 | 59 | 0.060 |
Why?
| Respiration, Artificial | 1 | 2005 | 320 | 0.060 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2022 | 91 | 0.060 |
Why?
| Multidetector Computed Tomography | 1 | 2022 | 56 | 0.060 |
Why?
| Protein Binding | 1 | 2005 | 1463 | 0.060 |
Why?
| Behavior, Animal | 1 | 2004 | 367 | 0.050 |
Why?
| Ambulances | 1 | 2000 | 13 | 0.050 |
Why?
| Multiple Trauma | 1 | 2000 | 33 | 0.050 |
Why?
| Sudden Infant Death | 1 | 2000 | 26 | 0.050 |
Why?
| Morbidity | 1 | 2020 | 141 | 0.050 |
Why?
| Anesthesia, Dental | 1 | 2019 | 4 | 0.050 |
Why?
| Analgesia, Obstetrical | 1 | 2019 | 19 | 0.050 |
Why?
| Analgesics, Non-Narcotic | 1 | 2019 | 47 | 0.050 |
Why?
| Conscious Sedation | 1 | 2019 | 73 | 0.050 |
Why?
| Rats | 1 | 2005 | 4145 | 0.050 |
Why?
| Hospital Mortality | 1 | 2020 | 318 | 0.050 |
Why?
| Infant, Newborn | 1 | 2004 | 2352 | 0.050 |
Why?
| Forecasting | 1 | 2019 | 309 | 0.050 |
Why?
| Databases, Factual | 1 | 2021 | 779 | 0.040 |
Why?
| Chronic Pain | 1 | 2019 | 109 | 0.040 |
Why?
| Intensive Care Units | 1 | 2000 | 361 | 0.040 |
Why?
| Evidence-Based Medicine | 1 | 2019 | 436 | 0.040 |
Why?
| Societies, Medical | 1 | 2019 | 558 | 0.040 |
Why?
| Sex Distribution | 1 | 2014 | 174 | 0.030 |
Why?
| Inpatients | 1 | 2012 | 268 | 0.020 |
Why?
| Adjuvants, Anesthesia | 1 | 2003 | 5 | 0.020 |
Why?
| Midazolam | 1 | 2003 | 48 | 0.020 |
Why?
| Anesthesia Recovery Period | 1 | 2003 | 71 | 0.020 |
Why?
| Intubation, Intratracheal | 1 | 2003 | 136 | 0.010 |
Why?
|
|
Nagele's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|